Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.88
Delayed Data
As of Mar 02
 +0.03 / +3.53%
Today’s Change
0.41
Today|||52-Week Range
2.10
+95.56%
Year-to-Date

Today’s Trading

Previous close0.85
Today’s open0.87
Day’s range-- - --
Volume615,620
Average volume (3 months)160,581
Market cap$43.0M
Dividend yield--
Data as of 03/02/2015

Growth & Valuation

Earnings growth (last year)-45.00%
Earnings growth (this year)-5.17%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales648.50
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
OGENOragenics Inc-0.10-8.70%
ALXAAlexza Pharmaceutica...-0.06-2.84%
IMNPImmune Pharmaceutica...-0.05-2.79%
CAPNCapnia Inc+0.11+1.75%
Data as of 03/02/2015

Financials

Last reporting dateMarch 3, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$123.0K
Annual profit (last year)-$13.9M
Net profit margin-11,301.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Robert B. Jones
Chief Financial Officer, Secretary &
Senior VP
Peter A. Clemens
Corporate headquarters
Palatine, Illinois

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account